Cargando…
Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D
This cross-sectional study examines the characteristics of prior authorization policies for new drugs in Medicare Part D to understand whether they are consistent with US Food and Drug Administration indications.
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Medical Association
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958521/ https://www.ncbi.nlm.nih.gov/pubmed/36826829 http://dx.doi.org/10.1001/jamahealthforum.2022.5610 |
| _version_ | 1784895043913383936 |
|---|---|
| author | Naci, Huseyin Forrest, Robin Zhai, Mike Stofesky, Amanda R. Kesselheim, Aaron S. |
| author_facet | Naci, Huseyin Forrest, Robin Zhai, Mike Stofesky, Amanda R. Kesselheim, Aaron S. |
| author_sort | Naci, Huseyin |
| collection | PubMed |
| description | This cross-sectional study examines the characteristics of prior authorization policies for new drugs in Medicare Part D to understand whether they are consistent with US Food and Drug Administration indications. |
| format | Online Article Text |
| id | pubmed-9958521 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | American Medical Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99585212023-02-26 Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D Naci, Huseyin Forrest, Robin Zhai, Mike Stofesky, Amanda R. Kesselheim, Aaron S. JAMA Health Forum Research Letter This cross-sectional study examines the characteristics of prior authorization policies for new drugs in Medicare Part D to understand whether they are consistent with US Food and Drug Administration indications. American Medical Association 2023-02-24 /pmc/articles/PMC9958521/ /pubmed/36826829 http://dx.doi.org/10.1001/jamahealthforum.2022.5610 Text en Copyright 2023 Naci H et al. JAMA Health Forum. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License. |
| spellingShingle | Research Letter Naci, Huseyin Forrest, Robin Zhai, Mike Stofesky, Amanda R. Kesselheim, Aaron S. Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D |
| title | Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D |
| title_full | Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D |
| title_fullStr | Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D |
| title_full_unstemmed | Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D |
| title_short | Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D |
| title_sort | characteristics of prior authorization policies for new drugs in medicare part d |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958521/ https://www.ncbi.nlm.nih.gov/pubmed/36826829 http://dx.doi.org/10.1001/jamahealthforum.2022.5610 |
| work_keys_str_mv | AT nacihuseyin characteristicsofpriorauthorizationpoliciesfornewdrugsinmedicarepartd AT forrestrobin characteristicsofpriorauthorizationpoliciesfornewdrugsinmedicarepartd AT zhaimike characteristicsofpriorauthorizationpoliciesfornewdrugsinmedicarepartd AT stofeskyamandar characteristicsofpriorauthorizationpoliciesfornewdrugsinmedicarepartd AT kesselheimaarons characteristicsofpriorauthorizationpoliciesfornewdrugsinmedicarepartd |